Loading…
Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis
It is not clear why some methamphetamine (MAMP) abusers develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We tested the hypotheses that those users who develop MAMP‐induced psychosis (MIP) have greater familial loading for psychotic disorders than us...
Saved in:
Published in: | American journal of medical genetics. Part B, Neuropsychiatric genetics Neuropsychiatric genetics, 2005-07, Vol.136B (1), p.87-91 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3 |
container_end_page | 91 |
container_issue | 1 |
container_start_page | 87 |
container_title | American journal of medical genetics. Part B, Neuropsychiatric genetics |
container_volume | 136B |
creator | Chen, Chih-Ken Lin, Shih-Ku Sham, Pak C. Ball, David Loh, El-Wui Murray, Robin M. |
description | It is not clear why some methamphetamine (MAMP) abusers develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We tested the hypotheses that those users who develop MAMP‐induced psychosis (MIP) have greater familial loading for psychotic disorders than users with no psychosis. Four hundred forty‐five MAMP users were recruited from a psychiatric hospital and a detention center in Taipei, and were assessed with the Diagnostic Interview for genetic studies (DIGS‐C) and the Family Interview for genetic study (FIGS‐C). Morbid risk (MR) for psychiatric disorders in first‐degree relatives was compared between those MAMP users with a lifetime diagnosis of MAMP psychosis and those without. The relatives of MAMP users with a lifetime diagnosis of MAMP psychosis had a significantly higher MR for schizophrenia (OR = 5.4, 95% CI: 2.0–14.7, P |
doi_str_mv | 10.1002/ajmg.b.30187 |
format | article |
fullrecord | <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ajmg_b_30187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_Q02G1QTF_L</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3</originalsourceid><addsrcrecordid>eNp9kE1PwkAURSdGI4juXJv5ARbno9PWJSFSNaAhwehuMtO-0oGWNjNF5N8LFHXn6t3FuSd5F6FrSvqUEHanFuW8r_uc0Cg8QV0qBPP8SHyc_mafdtCFcwtCOBFheI46VET3jArSRcWkstqk2Bq3xFllce22SW5UY02CU-Mqm4LFqqxWc9zkgC0UqjGf4HCV4RKaXJV1Do0qzQrw2oF1eGOaHKtVegjVummVlTPuEp1lqnBwdbw99DZ6mA0fvfFr_DQcjL3EJyz0OPc1qEAoXwGwxAedUSA0CBTjYQQJ14KoRAcJzXaPck64HwWpSinzw4Bp4D1023oTWzlnIZO1NaWyW0mJ3I8m96NJLQ-j7fCbFq_XuoT0Dz6utAN4C2xMAdt_ZXLwPIl_tF7bMq6Br9-WsksZhDwU8v0lllPCYjqdjeSYfwNnRoqF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Chen, Chih-Ken ; Lin, Shih-Ku ; Sham, Pak C. ; Ball, David ; Loh, El-Wui ; Murray, Robin M.</creator><creatorcontrib>Chen, Chih-Ken ; Lin, Shih-Ku ; Sham, Pak C. ; Ball, David ; Loh, El-Wui ; Murray, Robin M.</creatorcontrib><description>It is not clear why some methamphetamine (MAMP) abusers develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We tested the hypotheses that those users who develop MAMP‐induced psychosis (MIP) have greater familial loading for psychotic disorders than users with no psychosis. Four hundred forty‐five MAMP users were recruited from a psychiatric hospital and a detention center in Taipei, and were assessed with the Diagnostic Interview for genetic studies (DIGS‐C) and the Family Interview for genetic study (FIGS‐C). Morbid risk (MR) for psychiatric disorders in first‐degree relatives was compared between those MAMP users with a lifetime diagnosis of MAMP psychosis and those without. The relatives of MAMP users with a lifetime diagnosis of MAMP psychosis had a significantly higher MR for schizophrenia (OR = 5.4, 95% CI: 2.0–14.7, P < 0.001) than the relatives of those probands who never became psychotic. Furthermore, the MR for schizophrenia in the relatives of the subjects with a prolonged MAMP psychosis (MIP‐P) was higher than in the relatives of those users with a brief MAMP psychosis (MIP‐B) (OR = 2.8, 95% CI: 1.0–8.0, P = 0.042). The greater his or her familial loading for schizophrenia, the more likely a MAMP user is to develop psychosis, and the longer that psychosis is likely to last. © 2005 Wiley‐Liss, Inc.</description><identifier>ISSN: 1552-4841</identifier><identifier>EISSN: 1552-485X</identifier><identifier>DOI: 10.1002/ajmg.b.30187</identifier><identifier>PMID: 15892150</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; amphetamine ; Amphetamine-Related Disorders - epidemiology ; Amphetamine-Related Disorders - genetics ; Comorbidity ; familial risk ; Family ; Female ; genetic disposition ; Humans ; Interviews as Topic ; Male ; Mental Disorders - genetics ; Methamphetamine - poisoning ; Prevalence ; psychosis ; Psychotic Disorders - epidemiology ; Psychotic Disorders - etiology ; Risk Factors ; schizophrenia ; Schizophrenia - epidemiology ; Schizophrenia - genetics ; substance abuse</subject><ispartof>American journal of medical genetics. Part B, Neuropsychiatric genetics, 2005-07, Vol.136B (1), p.87-91</ispartof><rights>Copyright © 2005 Wiley‐Liss, Inc.</rights><rights>Copyright 2005 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3</citedby><cites>FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15892150$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Chih-Ken</creatorcontrib><creatorcontrib>Lin, Shih-Ku</creatorcontrib><creatorcontrib>Sham, Pak C.</creatorcontrib><creatorcontrib>Ball, David</creatorcontrib><creatorcontrib>Loh, El-Wui</creatorcontrib><creatorcontrib>Murray, Robin M.</creatorcontrib><title>Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis</title><title>American journal of medical genetics. Part B, Neuropsychiatric genetics</title><addtitle>Am. J. Med. Genet</addtitle><description>It is not clear why some methamphetamine (MAMP) abusers develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We tested the hypotheses that those users who develop MAMP‐induced psychosis (MIP) have greater familial loading for psychotic disorders than users with no psychosis. Four hundred forty‐five MAMP users were recruited from a psychiatric hospital and a detention center in Taipei, and were assessed with the Diagnostic Interview for genetic studies (DIGS‐C) and the Family Interview for genetic study (FIGS‐C). Morbid risk (MR) for psychiatric disorders in first‐degree relatives was compared between those MAMP users with a lifetime diagnosis of MAMP psychosis and those without. The relatives of MAMP users with a lifetime diagnosis of MAMP psychosis had a significantly higher MR for schizophrenia (OR = 5.4, 95% CI: 2.0–14.7, P < 0.001) than the relatives of those probands who never became psychotic. Furthermore, the MR for schizophrenia in the relatives of the subjects with a prolonged MAMP psychosis (MIP‐P) was higher than in the relatives of those users with a brief MAMP psychosis (MIP‐B) (OR = 2.8, 95% CI: 1.0–8.0, P = 0.042). The greater his or her familial loading for schizophrenia, the more likely a MAMP user is to develop psychosis, and the longer that psychosis is likely to last. © 2005 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>amphetamine</subject><subject>Amphetamine-Related Disorders - epidemiology</subject><subject>Amphetamine-Related Disorders - genetics</subject><subject>Comorbidity</subject><subject>familial risk</subject><subject>Family</subject><subject>Female</subject><subject>genetic disposition</subject><subject>Humans</subject><subject>Interviews as Topic</subject><subject>Male</subject><subject>Mental Disorders - genetics</subject><subject>Methamphetamine - poisoning</subject><subject>Prevalence</subject><subject>psychosis</subject><subject>Psychotic Disorders - epidemiology</subject><subject>Psychotic Disorders - etiology</subject><subject>Risk Factors</subject><subject>schizophrenia</subject><subject>Schizophrenia - epidemiology</subject><subject>Schizophrenia - genetics</subject><subject>substance abuse</subject><issn>1552-4841</issn><issn>1552-485X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PwkAURSdGI4juXJv5ARbno9PWJSFSNaAhwehuMtO-0oGWNjNF5N8LFHXn6t3FuSd5F6FrSvqUEHanFuW8r_uc0Cg8QV0qBPP8SHyc_mafdtCFcwtCOBFheI46VET3jArSRcWkstqk2Bq3xFllce22SW5UY02CU-Mqm4LFqqxWc9zkgC0UqjGf4HCV4RKaXJV1Do0qzQrw2oF1eGOaHKtVegjVummVlTPuEp1lqnBwdbw99DZ6mA0fvfFr_DQcjL3EJyz0OPc1qEAoXwGwxAedUSA0CBTjYQQJ14KoRAcJzXaPck64HwWpSinzw4Bp4D1023oTWzlnIZO1NaWyW0mJ3I8m96NJLQ-j7fCbFq_XuoT0Dz6utAN4C2xMAdt_ZXLwPIl_tF7bMq6Br9-WsksZhDwU8v0lllPCYjqdjeSYfwNnRoqF</recordid><startdate>20050705</startdate><enddate>20050705</enddate><creator>Chen, Chih-Ken</creator><creator>Lin, Shih-Ku</creator><creator>Sham, Pak C.</creator><creator>Ball, David</creator><creator>Loh, El-Wui</creator><creator>Murray, Robin M.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20050705</creationdate><title>Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis</title><author>Chen, Chih-Ken ; Lin, Shih-Ku ; Sham, Pak C. ; Ball, David ; Loh, El-Wui ; Murray, Robin M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>amphetamine</topic><topic>Amphetamine-Related Disorders - epidemiology</topic><topic>Amphetamine-Related Disorders - genetics</topic><topic>Comorbidity</topic><topic>familial risk</topic><topic>Family</topic><topic>Female</topic><topic>genetic disposition</topic><topic>Humans</topic><topic>Interviews as Topic</topic><topic>Male</topic><topic>Mental Disorders - genetics</topic><topic>Methamphetamine - poisoning</topic><topic>Prevalence</topic><topic>psychosis</topic><topic>Psychotic Disorders - epidemiology</topic><topic>Psychotic Disorders - etiology</topic><topic>Risk Factors</topic><topic>schizophrenia</topic><topic>Schizophrenia - epidemiology</topic><topic>Schizophrenia - genetics</topic><topic>substance abuse</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Chih-Ken</creatorcontrib><creatorcontrib>Lin, Shih-Ku</creatorcontrib><creatorcontrib>Sham, Pak C.</creatorcontrib><creatorcontrib>Ball, David</creatorcontrib><creatorcontrib>Loh, El-Wui</creatorcontrib><creatorcontrib>Murray, Robin M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of medical genetics. Part B, Neuropsychiatric genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Chih-Ken</au><au>Lin, Shih-Ku</au><au>Sham, Pak C.</au><au>Ball, David</au><au>Loh, El-Wui</au><au>Murray, Robin M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis</atitle><jtitle>American journal of medical genetics. Part B, Neuropsychiatric genetics</jtitle><addtitle>Am. J. Med. Genet</addtitle><date>2005-07-05</date><risdate>2005</risdate><volume>136B</volume><issue>1</issue><spage>87</spage><epage>91</epage><pages>87-91</pages><issn>1552-4841</issn><eissn>1552-485X</eissn><abstract>It is not clear why some methamphetamine (MAMP) abusers develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We tested the hypotheses that those users who develop MAMP‐induced psychosis (MIP) have greater familial loading for psychotic disorders than users with no psychosis. Four hundred forty‐five MAMP users were recruited from a psychiatric hospital and a detention center in Taipei, and were assessed with the Diagnostic Interview for genetic studies (DIGS‐C) and the Family Interview for genetic study (FIGS‐C). Morbid risk (MR) for psychiatric disorders in first‐degree relatives was compared between those MAMP users with a lifetime diagnosis of MAMP psychosis and those without. The relatives of MAMP users with a lifetime diagnosis of MAMP psychosis had a significantly higher MR for schizophrenia (OR = 5.4, 95% CI: 2.0–14.7, P < 0.001) than the relatives of those probands who never became psychotic. Furthermore, the MR for schizophrenia in the relatives of the subjects with a prolonged MAMP psychosis (MIP‐P) was higher than in the relatives of those users with a brief MAMP psychosis (MIP‐B) (OR = 2.8, 95% CI: 1.0–8.0, P = 0.042). The greater his or her familial loading for schizophrenia, the more likely a MAMP user is to develop psychosis, and the longer that psychosis is likely to last. © 2005 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15892150</pmid><doi>10.1002/ajmg.b.30187</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-4841 |
ispartof | American journal of medical genetics. Part B, Neuropsychiatric genetics, 2005-07, Vol.136B (1), p.87-91 |
issn | 1552-4841 1552-485X |
language | eng |
recordid | cdi_crossref_primary_10_1002_ajmg_b_30187 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Adult amphetamine Amphetamine-Related Disorders - epidemiology Amphetamine-Related Disorders - genetics Comorbidity familial risk Family Female genetic disposition Humans Interviews as Topic Male Mental Disorders - genetics Methamphetamine - poisoning Prevalence psychosis Psychotic Disorders - epidemiology Psychotic Disorders - etiology Risk Factors schizophrenia Schizophrenia - epidemiology Schizophrenia - genetics substance abuse |
title | Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A58%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Morbid%20risk%20for%20psychiatric%20disorder%20among%20the%20relatives%20of%20methamphetamine%20users%20with%20and%20without%20psychosis&rft.jtitle=American%20journal%20of%20medical%20genetics.%20Part%20B,%20Neuropsychiatric%20genetics&rft.au=Chen,%20Chih-Ken&rft.date=2005-07-05&rft.volume=136B&rft.issue=1&rft.spage=87&rft.epage=91&rft.pages=87-91&rft.issn=1552-4841&rft.eissn=1552-485X&rft_id=info:doi/10.1002/ajmg.b.30187&rft_dat=%3Cistex_cross%3Eark_67375_WNG_Q02G1QTF_L%3C/istex_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/15892150&rfr_iscdi=true |